Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells.
Sex and genetic factors determine skeletal mass, and we tested whether bone histomorphometric parameters were sexually dimorphic in femurs from 1 to 6 month old C57BL/6 mice. Trabecular bone volume declined more rapidly in female mice than in male littermates because of enhanced bone resorption. Although bone formation was not different between sexes, female mice exhibited a higher number of osteoblasts than male littermates, suggesting that osteoblasts from female mice may have a reduced ability to form bone. To determine the impact of sex on osteoblastogenesis, we investigated the potential for osteoblastic differentiation of bone marrow stromal cells from C57BL/6, Friend leukemia virus-B (FVB), C3H/HeJ and BALB/c mice of both sexes. Bone marrow stromal cells from female FVB, C57BL/6 and C3H/HeJ mice exhibited lower Alpl and Osteocalcin expression and alkaline phosphatase activity, and formed fewer mineralized nodules than cells from male littermates. Proliferative capacity was greater in cells from male than female C57BL/6, but not FVB, mice. Sorting of bone marrow stromal cells from mice expressing an α-Smooth muscle actin-green fluorescent protein transgene, revealed a higher yield of mesenchymal stem cells in cultures from male mice than in those from female littermates. Sex had a modest impact on osteoblastic differentiation of mesenchymal stem cells. To determine the influence of sex and genetic factors on osteoblast function, calvarial osteoblasts were harvested from C57BL/6, FVB, C3H/HeJ and BALB/c mice. Alpl expression and activity were lower in osteoblasts from C57BL/6 and C3H/HeJ, but not FVB or BALB/c, female mice than in cells from littermates. Sex had no effect on osteoclastogenesis of bone marrow cultures of C57BL/6 mice, but osteoblasts from female mice exhibited higher Rankl and lower Opg expression than cells from male littermates. In conclusion, osteoblastogenesis is sexually dimorphic and influenced by genetic factors.
Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States of America ; University of Connecticut School of Medicine, University of Connecticut Health Center, Farmington, Connecticut, United States of America.
Stefano
S
Zanotti
Department of Reconstructive Sciences, University of Connecticut Health Center, Farmington, Connecticut, United States of America.
Ivo
I
Kalajzic
Department of Immunology, University of Connecticut Health Center, Farmington, Connecticut, United States of America.
Hector Leonardo
HL
Aguila
Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States of America ; University of Connecticut School of Medicine, University of Connecticut Health Center, Farmington, Connecticut, United States of America.
Ernesto
E
Canalis
D000818:Animals; D002454:Cell Differentiation / Q000235:genetics*; D002478:Cells, Cultured; D005260:Female; D005269:Femur / Q000033:anatomy & histology / Q000166:cytology; D049452:Green Fluorescent Proteins / Q000378:metabolism; D008297:Male; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D008815:Mice, Inbred Strains; D008822:Mice, Transgenic; D010006:Osteoblasts / Q000166:cytology* / Q000378:metabolism; D010010:Osteoclasts / Q000166:cytology; D010012:Osteogenesis; D053244:Osteoprotegerin / Q000378:metabolism; D053245:RANK Ligand / Q000378:metabolism; D012727:Sex Characteristics; D012886:Skull / Q000166:cytology; D019076:Transgenes
D053244:Osteoprotegerin; D053245:RANK Ligand; D049452:Green Fluorescent Proteins